APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granisetron

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Granisetron Market Analysis and Forecast 2026-2032

22 December 2025201 pages

Choose your research edition.

Industry ResearchGranisetron Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Granisetron Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Granisetron Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granisetron Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Granisetron Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Granisetron market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Granisetron is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Granisetron is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Granisetron is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Granisetron is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Granisetron include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Granisetron, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Granisetron, also provides the revenue of main regions and countries. Of the upcoming market potential for Granisetron, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Granisetron revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Granisetron market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Granisetron revenue, projected growth trends, production technology, application and end-user industry.

Granisetron Segment by Company

Kyowa Kirin

Teva

Sandoz

Mylan

Fresenius Kabi

Wockhardt

Taro Pharmaceutical

Natco Pharma

Hikma Pharmaceuticals

Heron Therapeutics

Dr.Reddy's

Cipla

Bluepharma

Aurobindo

APOTEX

Akorn

Granisetron Segment by Type

Injection

Transdermal system

Oral

Granisetron Segment by Application

Chemotherapy

Post operative

Granisetron Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Granisetron in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Granisetron company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granisetron revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Granisetron Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Player Table 3. Transdermal system Major Player Table 4. Oral Major Player Table 5. Global Granisetron Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Chemotherapy Major Player Table 7. Post operative Major Player Table 8. Granisetron Industry Trends Table 9. Granisetron Industry Drivers Table 10. Granisetron Industry Opportunities and Challenges Table 11. Granisetron Industry Restraints Table 12. Global Granisetron Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Granisetron Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Granisetron Market Share by Region (2021-2026) Table 15. Global Granisetron Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Granisetron Market Share by Region (2027-2032) Table 17. Global Granisetron Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Granisetron Revenue Market Share by Players (2021-2026) Table 19. Global Granisetron Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Granisetron Key Players Headquarters & Area Served Table 21. Global Granisetron Players, Product Type & Application Table 22. Global Granisetron Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Granisetron by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Granisetron Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Granisetron Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Granisetron Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Granisetron Revenue Market Share by Type (2021-2026) Table 29. Global Granisetron Revenue Market Share by Type (2027-2032) Table 30. Global Granisetron Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Granisetron Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Granisetron Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Granisetron Revenue Market Share by Application (2021-2026) Table 34. Global Granisetron Revenue Market Share by Application (2027-2032) Table 35. Kyowa Kirin Company Information Table 36. Kyowa Kirin Business Overview Table 37. Kyowa Kirin Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Kyowa Kirin Granisetron Product Portfolio Table 39. Kyowa Kirin Recent Development Table 40. Teva Company Information Table 41. Teva Business Overview Table 42. Teva Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Granisetron Product Portfolio Table 44. Teva Recent Development Table 45. Sandoz Company Information Table 46. Sandoz Business Overview Table 47. Sandoz Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sandoz Granisetron Product Portfolio Table 49. Sandoz Recent Development Table 50. Mylan Company Information Table 51. Mylan Business Overview Table 52. Mylan Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Mylan Granisetron Product Portfolio Table 54. Mylan Recent Development Table 55. Fresenius Kabi Company Information Table 56. Fresenius Kabi Business Overview Table 57. Fresenius Kabi Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Fresenius Kabi Granisetron Product Portfolio Table 59. Fresenius Kabi Recent Development Table 60. Wockhardt Company Information Table 61. Wockhardt Business Overview Table 62. Wockhardt Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Wockhardt Granisetron Product Portfolio Table 64. Wockhardt Recent Development Table 65. Taro Pharmaceutical Company Information Table 66. Taro Pharmaceutical Business Overview Table 67. Taro Pharmaceutical Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Taro Pharmaceutical Granisetron Product Portfolio Table 69. Taro Pharmaceutical Recent Development Table 70. Natco Pharma Company Information Table 71. Natco Pharma Business Overview Table 72. Natco Pharma Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Natco Pharma Granisetron Product Portfolio Table 74. Natco Pharma Recent Development Table 75. Hikma Pharmaceuticals Company Information Table 76. Hikma Pharmaceuticals Business Overview Table 77. Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Hikma Pharmaceuticals Granisetron Product Portfolio Table 79. Hikma Pharmaceuticals Recent Development Table 80. Heron Therapeutics Company Information Table 81. Heron Therapeutics Business Overview Table 82. Heron Therapeutics Granisetron Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Heron Therapeutics Granisetron Product Portfolio Table 84. Heron Therapeutics Recent Development Table 85. Dr.Reddy's Company Information Table 86. Dr.Reddy's Business Overview Table 87. Dr.Reddy's Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Dr.Reddy's Granisetron Product Portfolio Table 89. Dr.Reddy's Recent Development Table 90. Cipla Company Information Table 91. Cipla Business Overview Table 92. Cipla Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Cipla Granisetron Product Portfolio Table 94. Cipla Recent Development Table 95. Bluepharma Company Information Table 96. Bluepharma Business Overview Table 97. Bluepharma Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Bluepharma Granisetron Product Portfolio Table 99. Bluepharma Recent Development Table 100. Aurobindo Company Information Table 101. Aurobindo Business Overview Table 102. Aurobindo Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Aurobindo Granisetron Product Portfolio Table 104. Aurobindo Recent Development Table 105. APOTEX Company Information Table 106. APOTEX Business Overview Table 107. APOTEX Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. APOTEX Granisetron Product Portfolio Table 109. APOTEX Recent Development Table 110. Akorn Company Information Table 111. Akorn Business Overview Table 112. Akorn Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Akorn Granisetron Product Portfolio Table 114. Akorn Recent Development Table 115. North America Granisetron Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Granisetron Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Granisetron Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Granisetron Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Granisetron Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Granisetron Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Granisetron Revenue by Country (US$ Million) & (2027-2032) Table 122. Europe Granisetron Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Granisetron Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Granisetron Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Granisetron Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Granisetron Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Granisetron Revenue by Country (2021-2026) & (US$ Million) Table 128. Europe Granisetron Revenue by Country (US$ Million) & (2027-2032) Table 129. China Granisetron Revenue by Type (2021-2026) & (US$ Million) Table 130. China Granisetron Revenue by Type (2027-2032) & (US$ Million) Table 131. China Granisetron Revenue by Application (2021-2026) & (US$ Million) Table 132. China Granisetron Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Granisetron Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Granisetron Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Granisetron Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Granisetron Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Granisetron Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Granisetron Revenue by Region (US$ Million) & (2021-2026) Table 139. Asia Granisetron Revenue by Region (US$ Million) & (2027-2032) Table 140. SAMEA Granisetron Revenue by Type (2021-2026) & (US$ Million) Table 141. SAMEA Granisetron Revenue by Type (2027-2032) & (US$ Million) Table 142. SAMEA Granisetron Revenue by Application (2021-2026) & (US$ Million) Table 143. SAMEA Granisetron Revenue by Application (2027-2032) & (US$ Million) Table 144. SAMEA Granisetron Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. SAMEA Granisetron Revenue by Country (2021-2026) & (US$ Million) Table 146. SAMEA Granisetron Revenue by Country (US$ Million) & (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Granisetron Image Figure 2. Global Granisetron Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granisetron Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Transdermal system Image Figure 6. Oral Image Figure 7. Global Granisetron Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Granisetron Market Size Share 2021 VS 2025 VS 2032 Figure 9. Chemotherapy Image Figure 10. Post operative Image Figure 11. Global Granisetron Market Size (US$ Million) & (2021-2032) Figure 12. Global Granisetron Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Granisetron Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Granisetron Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Granisetron Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Granisetron Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Granisetron Revenue Market Share by Type (2021-2032) Figure 19. Global Granisetron Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Granisetron Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Granisetron Revenue Market Share by Application (2021-2032) Figure 22. North America Granisetron Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Granisetron Revenue Share by Type (2021-2032) Figure 24. North America Granisetron Revenue Share by Application (2021-2032) Figure 25. North America Granisetron Revenue Share by Country (2021-2032) Figure 26. United States Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Granisetron Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Granisetron Revenue Share by Type (2021-2032) Figure 31. Europe Granisetron Revenue Share by Application (2021-2032) Figure 32. Europe Granisetron Revenue Share by Country (2021-2032) Figure 33. Germany Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Granisetron Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Granisetron Revenue Share by Type (2021-2032) Figure 43. China Granisetron Revenue Share by Application (2021-2032) Figure 44. Asia Granisetron Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Granisetron Revenue Share by Type (2021-2032) Figure 46. Asia Granisetron Revenue Share by Application (2021-2032) Figure 47. Asia Granisetron Revenue Share by Region (2021-2032) Figure 48. Japan Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Granisetron Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Granisetron Revenue Share by Type (2021-2032) Figure 56. SAMEA Granisetron Revenue Share by Application (2021-2032) Figure 57. SAMEA Granisetron Revenue Share by Country (2021-2032) Figure 58. Brazil Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Granisetron Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Transdermal system
  • Oral
Applications
  • Chemotherapy
  • Post operative
Companies covered
  • Kyowa Kirin
  • Teva
  • Sandoz
  • Mylan
  • Fresenius Kabi
  • Wockhardt
  • Taro Pharmaceutical
  • Natco Pharma
  • Hikma Pharmaceuticals
  • Heron Therapeutics
  • Dr.Reddy's
  • Cipla
  • Bluepharma
  • Aurobindo
  • APOTEX
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Granisetron Market by Type
  3. 1.2.1 Global Granisetron Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Transdermal system
  6. 1.2.4 Oral
  7. 1.3 Granisetron Market by Application
  8. 1.3.1 Global Granisetron Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Chemotherapy
  10. 1.3.3 Post operative
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Granisetron Market Dynamics
  1. 2.1 Granisetron Industry Trends
  2. 2.2 Granisetron Industry Drivers
  3. 2.3 Granisetron Industry Opportunities and Challenges
  4. 2.4 Granisetron Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Granisetron Market Perspective (2021-2032)
  2. 3.2 Global Granisetron Growth Trends by Region
  3. 3.2.1 Global Granisetron Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Granisetron Market Size by Region (2021-2026)
  5. 3.2.3 Global Granisetron Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Granisetron Revenue by Players
  2. 4.1.1 Global Granisetron Revenue by Players (2021-2026)
  3. 4.1.2 Global Granisetron Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Granisetron Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Granisetron Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Granisetron Key Players Headquarters & Area Served
  7. 4.4 Global Granisetron Players, Product Type & Application
  8. 4.5 Global Granisetron Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Granisetron Market CR5 and HHI
  11. 4.6.3 2025 Granisetron Tier 1, Tier 2, and Tier 3
5 Granisetron Market Size by Type
  1. 5.1 Global Granisetron Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Granisetron Revenue by Type (2021-2032)
  3. 5.3 Global Granisetron Revenue Market Share by Type (2021-2032)
6 Granisetron Market Size by Application
  1. 6.1 Global Granisetron Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Granisetron Revenue by Application (2021-2032)
  3. 6.3 Global Granisetron Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Kyowa Kirin
  2. 7.1.1 Kyowa Kirin Company Information
  3. 7.1.2 Kyowa Kirin Business Overview
  4. 7.1.3 Kyowa Kirin Granisetron Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Kyowa Kirin Granisetron Product Portfolio
  6. 7.1.5 Kyowa Kirin Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Granisetron Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Granisetron Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sandoz
  14. 7.3.1 Sandoz Company Information
  15. 7.3.2 Sandoz Business Overview
  16. 7.3.3 Sandoz Granisetron Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sandoz Granisetron Product Portfolio
  18. 7.3.5 Sandoz Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Granisetron Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Granisetron Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Fresenius Kabi
  26. 7.5.1 Fresenius Kabi Company Information
  27. 7.5.2 Fresenius Kabi Business Overview
  28. 7.5.3 Fresenius Kabi Granisetron Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Fresenius Kabi Granisetron Product Portfolio
  30. 7.5.5 Fresenius Kabi Recent Developments
  31. 7.6 Wockhardt
  32. 7.6.1 Wockhardt Company Information
  33. 7.6.2 Wockhardt Business Overview
  34. 7.6.3 Wockhardt Granisetron Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Wockhardt Granisetron Product Portfolio
  36. 7.6.5 Wockhardt Recent Developments
  37. 7.7 Taro Pharmaceutical
  38. 7.7.1 Taro Pharmaceutical Company Information
  39. 7.7.2 Taro Pharmaceutical Business Overview
  40. 7.7.3 Taro Pharmaceutical Granisetron Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Taro Pharmaceutical Granisetron Product Portfolio
  42. 7.7.5 Taro Pharmaceutical Recent Developments
  43. 7.8 Natco Pharma
  44. 7.8.1 Natco Pharma Company Information
  45. 7.8.2 Natco Pharma Business Overview
  46. 7.8.3 Natco Pharma Granisetron Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Natco Pharma Granisetron Product Portfolio
  48. 7.8.5 Natco Pharma Recent Developments
  49. 7.9 Hikma Pharmaceuticals
  50. 7.9.1 Hikma Pharmaceuticals Company Information
  51. 7.9.2 Hikma Pharmaceuticals Business Overview
  52. 7.9.3 Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hikma Pharmaceuticals Granisetron Product Portfolio
  54. 7.9.5 Hikma Pharmaceuticals Recent Developments
  55. 7.10 Heron Therapeutics
  56. 7.10.1 Heron Therapeutics Company Information
  57. 7.10.2 Heron Therapeutics Business Overview
  58. 7.10.3 Heron Therapeutics Granisetron Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Heron Therapeutics Granisetron Product Portfolio
  60. 7.10.5 Heron Therapeutics Recent Developments
  61. 7.11 Dr.Reddy's
  62. 7.11.1 Dr.Reddy's Company Information
  63. 7.11.2 Dr.Reddy's Business Overview
  64. 7.11.3 Dr.Reddy's Granisetron Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Dr.Reddy's Granisetron Product Portfolio
  66. 7.11.5 Dr.Reddy's Recent Developments
  67. 7.12 Cipla
  68. 7.12.1 Cipla Company Information
  69. 7.12.2 Cipla Business Overview
  70. 7.12.3 Cipla Granisetron Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Cipla Granisetron Product Portfolio
  72. 7.12.5 Cipla Recent Developments
  73. 7.13 Bluepharma
  74. 7.13.1 Bluepharma Company Information
  75. 7.13.2 Bluepharma Business Overview
  76. 7.13.3 Bluepharma Granisetron Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bluepharma Granisetron Product Portfolio
  78. 7.13.5 Bluepharma Recent Developments
  79. 7.14 Aurobindo
  80. 7.14.1 Aurobindo Company Information
  81. 7.14.2 Aurobindo Business Overview
  82. 7.14.3 Aurobindo Granisetron Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Aurobindo Granisetron Product Portfolio
  84. 7.14.5 Aurobindo Recent Developments
  85. 7.15 APOTEX
  86. 7.15.1 APOTEX Company Information
  87. 7.15.2 APOTEX Business Overview
  88. 7.15.3 APOTEX Granisetron Revenue and Gross Margin (2021-2026)
  89. 7.15.4 APOTEX Granisetron Product Portfolio
  90. 7.15.5 APOTEX Recent Developments
  91. 7.16 Akorn
  92. 7.16.1 Akorn Company Information
  93. 7.16.2 Akorn Business Overview
  94. 7.16.3 Akorn Granisetron Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Akorn Granisetron Product Portfolio
  96. 7.16.5 Akorn Recent Developments
8 North America
  1. 8.1 North America Granisetron Revenue (2021-2032)
  2. 8.2 North America Granisetron Revenue by Type (2021-2032)
  3. 8.2.1 North America Granisetron Revenue by Type (2021-2026)
  4. 8.2.2 North America Granisetron Revenue by Type (2027-2032)
  5. 8.3 North America Granisetron Revenue Share by Type (2021-2032)
  6. 8.4 North America Granisetron Revenue by Application (2021-2032)
  7. 8.4.1 North America Granisetron Revenue by Application (2021-2026)
  8. 8.4.2 North America Granisetron Revenue by Application (2027-2032)
  9. 8.5 North America Granisetron Revenue Share by Application (2021-2032)
  10. 8.6 North America Granisetron Revenue by Country
  11. 8.6.1 North America Granisetron Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Granisetron Revenue by Country (2021-2026)
  13. 8.6.3 North America Granisetron Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Granisetron Revenue (2021-2032)
  2. 9.2 Europe Granisetron Revenue by Type (2021-2032)
  3. 9.2.1 Europe Granisetron Revenue by Type (2021-2026)
  4. 9.2.2 Europe Granisetron Revenue by Type (2027-2032)
  5. 9.3 Europe Granisetron Revenue Share by Type (2021-2032)
  6. 9.4 Europe Granisetron Revenue by Application (2021-2032)
  7. 9.4.1 Europe Granisetron Revenue by Application (2021-2026)
  8. 9.4.2 Europe Granisetron Revenue by Application (2027-2032)
  9. 9.5 Europe Granisetron Revenue Share by Application (2021-2032)
  10. 9.6 Europe Granisetron Revenue by Country
  11. 9.6.1 Europe Granisetron Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Granisetron Revenue by Country (2021-2026)
  13. 9.6.3 Europe Granisetron Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Granisetron Revenue (2021-2032)
  2. 10.2 China Granisetron Revenue by Type (2021-2032)
  3. 10.2.1 China Granisetron Revenue by Type (2021-2026)
  4. 10.2.2 China Granisetron Revenue by Type (2027-2032)
  5. 10.3 China Granisetron Revenue Share by Type (2021-2032)
  6. 10.4 China Granisetron Revenue by Application (2021-2032)
  7. 10.4.1 China Granisetron Revenue by Application (2021-2026)
  8. 10.4.2 China Granisetron Revenue by Application (2027-2032)
  9. 10.5 China Granisetron Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Granisetron Revenue (2021-2032)
  2. 11.2 Asia Granisetron Revenue by Type (2021-2032)
  3. 11.2.1 Asia Granisetron Revenue by Type (2021-2026)
  4. 11.2.2 Asia Granisetron Revenue by Type (2027-2032)
  5. 11.3 Asia Granisetron Revenue Share by Type (2021-2032)
  6. 11.4 Asia Granisetron Revenue by Application (2021-2032)
  7. 11.4.1 Asia Granisetron Revenue by Application (2021-2026)
  8. 11.4.2 Asia Granisetron Revenue by Application (2027-2032)
  9. 11.5 Asia Granisetron Revenue Share by Application (2021-2032)
  10. 11.6 Asia Granisetron Revenue by Country
  11. 11.6.1 Asia Granisetron Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Granisetron Revenue by Country (2021-2026)
  13. 11.6.3 Asia Granisetron Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Granisetron Revenue (2021-2032)
  2. 12.2 SAMEA Granisetron Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Granisetron Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Granisetron Revenue by Type (2027-2032)
  5. 12.3 SAMEA Granisetron Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Granisetron Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Granisetron Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Granisetron Revenue by Application (2027-2032)
  9. 12.5 SAMEA Granisetron Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Granisetron Revenue by Country
  11. 12.6.1 SAMEA Granisetron Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Granisetron Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Granisetron Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst